Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | GAA | P10253 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 3/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10661614 | 0.87 | CYP3A4 (0.57) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL27286151 | 0.87 | MAPT (0.55) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL9401812 | 0.87 | CACNA1B (0.65) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL10635540 | 0.86 | MAPT (0.39) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL10664938 | 0.86 | MAPT (0.44) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL11013178 | 0.85 | CACNA1F (0.59) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL11314878 | 0.84 | ALDH1A1 (0.44) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL28762620 | 0.81 | CACNA1B (0.51) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL7267468 | 0.80 | CACNA1B (0.47) | CACNA1BMAPTALDH1A1GAAHPGD | |
| SCHEMBL7272316 | 0.80 | CACNA1F (0.62) | CACNA1BMAPTALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140088056-A1 | CARDIAC GLYCOSIDES ARE POTENT INHIBITORS OF INTERFERON-BETA GENE EXPRESSION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-03-27 | — | — | US | claimed |
| US-5580871-A | FOR TREATMENT OF CONGESTIVE HEART FAILURE | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-12-03 | — | — | US | claimed |
| US-11963964-B2 | Small molecules for mouse satellite cell proliferation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-04-23 | — | — | US | disclosed |
| US-11026952-B2 | Small molecules for mouse satellite cell proliferation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-06-08 | — | — | US | disclosed |
| US-20200352957-A1 | SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2020-11-12 | — | — | US | disclosed |
| US-10660902-B2 | Method of increasing satellite cell proliferation with an HDAC inhibitor | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-05-26 | — | — | US | disclosed |
| EP-3411040-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | President and Fellows of Harvard College (US) | 2018-12-12 | — | — | EP | disclosed |
| US-20180153902-A1 | SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION | HOWARD HUGHES MEDICAL INSTITUTE | 2018-06-07 | — | — | US | disclosed |
| US-9782417-B2 | Methods of increasing satellite cell proliferation with kinase inhibitors | PRESIDENTS AND FELLOWS OF HARVARD COLLEGE (US) | 2017-10-10 | — | — | US | disclosed |
| WO-2017136480-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-08-10 | — | — | WO | disclosed |
| US-20160220580-A1 | SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-08-04 | — | — | US | disclosed |
| US-20120310140-A1 | DIRECTED DELIVERY OF AGENTS TO NEURAL ANATOMY | SPINAL MODULATION, INC. (US) | 2012-12-06 | — | — | US | disclosed |
| US-5580871-A | FOR TREATMENT OF CONGESTIVE HEART FAILURE | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-12-03 | — | — | US | disclosed |
| US-5432188-A | Treating congestive heart failure | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-07-11 | — | — | US | disclosed |
| EP-0458823-B1 | A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE POLYSUBSTITUTED 1,4-DIHYDROPYRIDINES | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1993-10-13 | — | — | EP | disclosed |
| US-5245039-A | PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE POLYSUBSTITUTED 1,4-DIHYDROPYRIDINES | BOEHRINGER MANNHEIM ITALIA (IT) | 1993-09-14 | — | — | US | disclosed |
| US-5166147-A | Congestive heart failure | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-11-24 | — | — | US | disclosed |
| EP-0458823-A1 | A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE POLYSUBSTITUTED 1,4-DIHYDROPYRIDINES. | BOEHRINGER MANNHEIM ITALIA (IT) | 1991-12-04 | — | — | EP | disclosed |
| WO-1990009376-A1 | A PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE POLYSUBSTITUTED 1,4-DIHYDROPYRIDINES | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1990-08-23 | — | — | WO | disclosed |
| EP-0383320-A1 | A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1990-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11026952-B2 | Small molecules for mouse satellite cell proliferation | MKI67, MYLK2, MYH2 | CACNA1B 2567/4885MAPT 4150/4885ALDH1A1 2684/4885 |
| US-10660902-B2 | Method of increasing satellite cell proliferation with an HDAC inhibitor | HDAC4, HDAC1, HDAC5 | CACNA1B 3247/4885MAPT 3910/4885ALDH1A1 1712/4885 |
| US-20180153902-A1 | SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION | MKI67, MYLK2, MYH2 | CACNA1B 2242/4885MAPT 4009/4885ALDH1A1 2772/4885 |
| US-11963964-B2 | Small molecules for mouse satellite cell proliferation | MKI67, MYLK2, MYH2 | CACNA1B 2567/4885MAPT 4150/4885ALDH1A1 2684/4885 |
| US-20200352957-A1 | SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION | MKI67, MYLK2, MYH2 | CACNA1B 2242/4885MAPT 4009/4885ALDH1A1 2772/4885 |
| US-20160220580-A1 | SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION | MKI67, MYLK2, MYH2 | CACNA1B 2242/4885MAPT 4009/4885ALDH1A1 2772/4885 |
| US-20140088056-A1 | CARDIAC GLYCOSIDES ARE POTENT INHIBITORS OF INTERFERON-BETA GENE EXPRESSION | IRF3, IFNG, STING1 | CACNA1B 135/4885MAPT 4814/4885ALDH1A1 4075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.